Alternative Investment Funds (AIF)
Compare Schemes

SAMEEKSHA INDIA EQUITY FUND vs WhiteOak Capital Healthcare Opportunities Fund

SAMEEKSHA INDIA EQUITY FUND
WhiteOak Capital Healthcare Opportunities Fund
Add Scheme
Growth of ₹1 Crore
SAMEEKSHA INDIA EQUITY FUND
WhiteOak Capital Healthcare Opportunities Fund
Return for the risk
3 yrs return
5%
10%
15%
20%
25%
30%
Nifty 500 · 11.9%
10%
20%
30%
Volatility • 3 yrs deviation
1 Month
4.04%
2.98%
6 Months
14.10%
24.80%
1 Year
7.50%
10.37%
3 Years
22.84%
—
5 Years
—
—
Since Inception
23.58%
16.92%
Fund Age
4 yrs 5 mo
14 mo
AUM
₹1,282.88 Cr
₹151.93 Cr
Alpha – 1 Year
4.52%
−2.16%
Alpha – 3 Years
10.95%
—
Information Ratio – 3 Years
0.98
—
Volatility – 1 Year
21.85%
15.91%
Volatility – 3 Years
16.29%
—
Beta – 1 Year
1.19
0.63
Beta – 3 Years
0.92
—
Sharpe Ratio – 1 Year
0.18
0.35
Sharpe Ratio – 3 Years
0.98
—
Worst Rolling Year
22.35%
8.71%
Value at Worst Rolling Year
₹1.22 Cr
₹1.09 Cr
Deepest Drawdown
−17.55%
−12.14%
Recovery Period
91 days
Not yet recovered
1-Year Rolling Windows Positive
100.00%
100.00%
Median Rolling Year
28.61%
8.71%
5-Year Rolling Windows Positive
—
—
Market-Cap Mix
L 23% · M 12% · S 64%
M 16% · S 83%
Number of Stocks
—
38
Portfolio P/E
—
62.12
Top 5 Holdings
—
Sai Life Sciences Ltd · 4.85%
J B Chemicals & Pharmaceuticals Ltd · 4.58%
Vijaya Diagnostic Centre Ltd · 4.46%
Shaily Engineering Plastics Ltd · 4.40%
Krishna Institute of Medical Sciences Ltd · 4.36%
Top Sectors
—
Healthcare · 88.35%
Chemicals · 5.60%
Consumer Durables · 4.40%
Fixed Fee
—
—
Performance Fee / Plan
—
—
Exit Load (Y1 / Y2 / Y3)
—
—
Let's start a
conversation
  • Compare this PMS against 3,000+ others with our research desk
  • Build a long-term portfolio around your goals, not a one-off buy
  • Experts with decades of experience.
Private. Personal. No obligation.
We will only use these details to contact you about this enquiry. No spam.
Start a conversation
Share a few details and an expert will reach out.
We will only use these details to contact you about this enquiry. No spam.